{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:49:55Z","timestamp":1792018195313,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":71,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008417","name":"Agency for Health Care Policy and Research","doi-asserted-by":"publisher","award":["K08HS026008-0"],"award-info":[{"award-number":["K08HS026008-0"]}],"id":[{"id":"10.13039\/100008417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006954","name":"Tufts Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.gastha.2023.03.016","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T22:18:23Z","timestamp":1678918703000},"page":"660-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Impact of Incarceration on Readmissions Among Patients With Inflammatory Bowel Disease Hospitalized at a Community Hospital"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2767-2355","authenticated-orcid":false,"given":"Katherine M.","family":"Rich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubeen","family":"Guardado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahna R.","family":"Bigham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okechi","family":"Boms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alysse G.","family":"Wurcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2023.03.016_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.mcna.2007.12.002","article-title":"Severe complications of inflammatory bowel disease","volume":"92","author":"Marrero","year":"2008","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.gastha.2023.03.016_bib3","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1097\/MIB.0b013e31829936c2","article-title":"Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"19","author":"Costa","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastha.2023.03.016_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2013.09.032","article-title":"Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis","volume":"146","author":"Feagan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2023.03.016_bib5","series-title":"The impact of biological interventions for ulcerative colitis on health-related quality of life","author":"LeBlanc","year":"2015"},{"key":"10.1016\/j.gastha.2023.03.016_bib6","doi-asserted-by":"crossref","first-page":"S500","DOI":"10.1038\/ajg.2013.269","article-title":"Characteristic of patients with inflammatory bowel disease who reside in the department of Corrections in Connecticut: 1667","volume":"108","author":"Ynson","year":"2013","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"10.1016\/j.gastha.2023.03.016_bib7","first-page":"574","article-title":"Epidemiology of infectious disease-related death after release from prison, Washington state, United States, and Queensland, Australia: a cohort study","volume":"131","author":"Binswanger","year":"2016","journal-title":"Public Health Rep Wash DC 1974"},{"key":"10.1016\/j.gastha.2023.03.016_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastha.2023.03.016_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1353\/hpu.2020.0037","article-title":"The african American petri dish","volume":"31","author":"Braithwaite","year":"2020","journal-title":"J\u00a0Health Care Poor Underserved"},{"key":"10.1016\/j.gastha.2023.03.016_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(17)31869-X","article-title":"Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis","volume":"391","author":"Aldridge","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.gastha.2023.03.016_bib11","doi-asserted-by":"crossref","first-page":"ofab579","DOI":"10.1093\/ofid\/ofab579","article-title":"Hepatitis C virus is associated with increased mortality among incarcerated hospitalized persons in Massachusetts","volume":"8","author":"Wurcel","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.gastha.2023.03.016_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.gastha.2023.03.016_bib13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/archsurg.2011.194","article-title":"Risk of comorbidities on postoperative outcomes in patients with inflammatory bowel disease","volume":"146","author":"Kaplan","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/j.gastha.2023.03.016_bib14","doi-asserted-by":"crossref","first-page":"S446","DOI":"10.14309\/00000434-200809001-01142","article-title":"Predicting postoperative mortality from comorbidity indices in administrative databases among inflammatory bowel disease patients: 1142","volume":"103","author":"Kaplan","year":"2008","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"10.1016\/j.gastha.2023.03.016_bib16","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA clinical practice Guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2023.03.016_bib17","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1007\/s10620-019-05594-7","article-title":"Market access analysis of biologics and small-molecule inhibitors for inflammatory bowel disease among US health insurance policies","volume":"64","author":"Dulai","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastha.2023.03.016_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250901","article-title":"\u201cI'm not gonna be able to do anything about it, then what's the point?\u201d: a broad group of stakeholders identify barriers and facilitators to HCV testing in a Massachusetts jail","volume":"16","author":"Wurcel","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.gastha.2023.03.016_bib19","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1377\/hlthaff.2016.0296","article-title":"New hepatitis C drugs are very costly and unavailable to many state prisoners","volume":"35","author":"Beckman","year":"2016","journal-title":"Health Aff Proj Hope"},{"key":"10.1016\/j.gastha.2023.03.016_bib20","first-page":"467","article-title":"The Burden of untreated HCV infection in hospitalized inmates: a hospital utilization and cost analysis","volume":"95","author":"Wurcel","year":"2018","journal-title":"J\u00a0Urban Health Bull N Y Acad Med"},{"key":"10.1016\/j.gastha.2023.03.016_bib21","unstructured":"Prisoner settles suit over failure to treat Crohn's disease | prison legal news. https:\/\/www.prisonlegalnews.org\/news\/2012\/may\/15\/prisoner-settles-suit-over-failure-to-treat-crohns-disease\/. Accessed September 27,\u00a02021."},{"key":"10.1016\/j.gastha.2023.03.016_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819827692","article-title":"Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010","volume":"12","author":"Aniwan","year":"2019","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.gastha.2023.03.016_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ibd\/izz104","article-title":"The cost of inflammatory bowel disease: an initiative from the Crohn's & colitis foundation","volume":"26","author":"Park","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastha.2023.03.016_bib24","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","article-title":"Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults","volume":"135","author":"Kappelman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2023.03.016_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/MIB.0000000000001121","article-title":"Modifiable risk factors for hospital readmission among patients with inflammatory bowel disease in a nationwide database","volume":"23","author":"Barnes","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastha.2023.03.016_bib26","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1097\/MIB.0000000000001242","article-title":"Inflammatory bowel disease: predictors and causes of early and late hospital readmissions","volume":"23","author":"Mudireddy","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastha.2023.03.016_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182900","article-title":"Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease","volume":"12","author":"Micic","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.gastha.2023.03.016_bib28","first-page":"474","article-title":"Inflammatory bowel disease readmissions are associated with utilization and comorbidity","volume":"25","author":"Cohen-Mekelburg","year":"2019","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.gastha.2023.03.016_bib29","first-page":"2","article-title":"Drug formularies in correctional settings","volume":"48","author":"Morris","year":"2020","journal-title":"J\u00a0Am Acad Psychiatry L"},{"key":"10.1016\/j.gastha.2023.03.016_bib30","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4065\/81.11.1462","article-title":"Smoking and inflammatory bowel disease: a meta-analysis","volume":"81","author":"Mahid","year":"2006","journal-title":"Mayo Clin Proc"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572323000511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572323000511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:34:57Z","timestamp":1757417697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572323000511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"alternative-id":["S2772572323000511"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2023.03.016","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Incarceration on Readmissions Among Patients With Inflammatory Bowel Disease Hospitalized at a Community Hospital","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2023.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}